Literature DB >> 3855649

Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission.

A M Dickinson, S J Proctor, E Jacobs, M M Reid, W Walker, A W Craft, J Kernahan.   

Abstract

Fifteen children with acute lymphoblastic leukaemia (ALL) in remission receiving maintenance chemotherapy and 12 ALL patients off treatment and in remission were tested for natural killer (NK) cell activity in vitro. Compared with a control population the children with ALL receiving maintenance chemotherapy had low levels of NK cell activity. This effect was not due to a specific reduction in NK cell numbers since proportions of mononuclear cells detected by the monoclonal antibodies HNK-1 (Leu-7) and Leu-11a were normal. Furthermore NK cell activity in patients could only be partially increased by pre-incubation of effector cells with interferon (alpha IFN). These studies confirm the lack of NK cell activity in children with ALL and show that this phenomenon is directly related to functional NK cell impairment. Our study has further shown that this effect is transient since ALL patients off treatment and in remission showed normal levels and augmentation of NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855649     DOI: 10.1111/j.1365-2141.1985.tb02962.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia.

Authors:  Yorleny Vicioso; Hermann Gram; Rose Beck; Abhishek Asthana; Keman Zhang; Derek P Wong; John Letterio; Reshmi Parameswaran
Journal:  Cancer Immunol Res       Date:  2019-05-28       Impact factor: 11.151

2.  Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexate.

Authors:  T Nakarai; Y Ueno; Y Ueno; S Koizumi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Loss of natural killer activity as an indicator of relapse in acute leukaemia.

Authors:  J A Tratkiewicz; J Szer
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  In vitro enhancement of natural killer cell activity against herpesvirus-infected targets in patients with acute lymphocytic leukemia.

Authors:  J R McKolanis; A H Ragab; D S Schmid
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Defects of natural killer cell activity in children with untreated acute lymphocytic leukemia.

Authors:  J Gabrilovac; M Boranić; B Kusić; D Batinić; L Rajić; A Tiefenbach
Journal:  Klin Wochenschr       Date:  1988-04-15

6.  Lymphokine-activated killer cytotoxicity against leukaemic blast cells.

Authors:  J A Tratkiewicz; J Szer; R L Boyd
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

7.  NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.

Authors:  Erin M Sullivan; Sima Jeha; Guolian Kang; Cheng Cheng; Barbara Rooney; Martha Holladay; Rafijul Bari; Sarah Schell; MaCal Tuggle; Ching-Hon Pui; Wing Leung
Journal:  Clin Cancer Res       Date:  2014-10-03       Impact factor: 12.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.